N-(4-吡啶甲基)-甲基磺酰胺 | 349404-63-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: N-(4-吡啶甲基)-甲基磺酰胺
• 英文名称: N-(pyridin-4-ylmethyl)methanesulfonamide
• CAS: 349404-63-3
• 化学式: C₇H₁₀N₂O₂S
• mdl: MFCD02807877
• 分子量: 186.23
• InChiKey: GXTRLSHMRCBPBJ-UHFFFAOYSA-N

物化性质

• 沸点：
  354.6±44.0 °C(Predicted)
• 密度：
  1.281±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.285
• 拓扑面积：
  67.4
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• [EN] N-(1-ARYLPYRAZOL-4L)SULFONAMIDES AND THEIR USE AS PARASITICIDES<br/>[FR] SULFAMIDES N-(1-ARYLPYRAZOL-4L) ET LEUR UTILISATION EN TANT QU'ANTI-PARASITAIRES
  申请人：PFIZER LTD

  公开号：WO2005090313A1

  公开（公告）日：2005-09-29

  The invention relates to a sulfonamide compound of formula (I) or a pharmaceutically, veterinarily or agriculturally acceptable salt or solvate thereof, where the groups R1-R5 are described in the description, to compositions comprising such compounds, processes for their synthesis and their use as parasiticides.

  这项发明涉及一种化合物，其化学式为(I)的磺胺类化合物，或其在药学、兽医学或农业上可接受的盐或溶剂，其中R1-R5基团在描述中有所描述，以及包含这些化合物的组合物，其合成过程以及它们作为驱虫剂的用途。
• Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
  申请人：——

  公开号：US20040162318A1

  公开（公告）日：2004-08-19

  The present invention relates to novel benzofuran derivatives and analogs, as well as compositions containing the same and to the use thereof for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by the hepatitis C virus.

  本发明涉及新型苯并呋喃衍生物和类似物，以及含有它们的组合物，以及将它们用于治疗或预防与病毒感染有关的疾病，特别是由丙型肝炎病毒引起的病毒感染和相关疾病的用途。
• BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES
  申请人：Saha K. Ashis

  公开号：US20070231318A1

  公开（公告）日：2007-10-04

  The present invention relates to novel benzofuran derivatives and analogs, as well as compositions containing the same and to the use thereof for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by the hepatitis C virus.

  本发明涉及新型苯并呋喃衍生物和类似物，以及含有它们的组合物，以及将其用于治疗或预防病毒感染和与之相关的疾病，特别是由丙型肝炎病毒引起的病毒感染和相关疾病。
• HYDRAZIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR
  申请人：Miyaji Katsuaki

  公开号：US20090253751A1

  公开（公告）日：2009-10-08

  Compounds effective for preventing, treatment or improving diseases against which activation of the thrombopoietin receptor is effective are provided. A compound represented by the formula (I) (wherein R 1 , R 2 , R 3 , L 1 , L 2 , X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.

  提供了一种用于预防、治疗或改善激活血小板生成素受体有效对抗的疾病的化合物。该化合物由式(I)所表示（其中R1、R2、R3、L1、L2、X和Y在描述中被定义），该化合物的互变异构体、前药或药物可接受的盐或其溶剂化物。
• PYRIDINE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS
  申请人：ELI LILLY AND COMPANY

  公开号：EP1255735A2

  公开（公告）日：2002-11-13